Active, not recruiting
Study of Cabozantinib in Combination With Atezolizumab Versus Sorafenib in Participants With Advanced Hepatocellular Carcinoma (HCC) Who Have Not Received Previous Systemic Anticancer Therapy
NCT03755791
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
- Exelixis Clinical Site #208 Phoenix, Arizona, United States
- Exelixis Clinical Site #159 Tucson, Arizona, United States
- Exelixis Clinical Site #44 La Jolla, California, United States
- Exelixis Clinical Site #112 Los Angeles, California, United States